Temporary interruption of baricitinib: characterization of interruptions and effect on clinical outcomes in patients with rheumatoid arthritis

BACKGROUND: In clinical practice, temporary interruption of rheumatoid arthritis (RA) therapy is common for various reasons including side effects, non-compliance, or necessity for surgery. To characterize temporary interruptions of baricitinib and placebo-matched tablets in phase 3 studies of patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Emery, Paul, Tanaka, Yoshiya, Cardillo, Tracy, Schlichting, Douglas, Rooney, Terence, Beattie, Scott, Helt, Cameron, Smolen, Josef S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7227095/
https://www.ncbi.nlm.nih.gov/pubmed/32414425
http://dx.doi.org/10.1186/s13075-020-02199-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7227095/
https://www.ncbi.nlm.nih.gov/pubmed/32414425
http://dx.doi.org/10.1186/s13075-020-02199-8

Ejemplares similares